Jay R. Luly

2014

In 2014, Jay R. Luly earned a total compensation of $2.5M as President and Chief Executive Officer at Enanta Pharmaceuticals, a 53% increase compared to previous year.

Compensation breakdown

Bonus$262,455
Option Awards$1,755,908
Salary$489,382
Other$11,369
Total$2,519,114

Luly received $1.8M in option awards, accounting for 70% of the total pay in 2014.

Luly also received $262.5K in bonus, $489.4K in salary and $11.4K in other compensation.

Rankings

In 2014, Jay R. Luly's compensation ranked 3,621st out of 13,032 executives tracked by ExecPay. In other words, Luly earned more than 72.2% of executives.

ClassificationRankingPercentile
All
3,621
out of 13,032
72nd
Division
Manufacturing
1,275
out of 4,967
74th
Major group
Chemicals And Allied Products
414
out of 1,690
76th
Industry group
Drugs
320
out of 1,369
77th
Industry
Pharmaceutical Preparations
260
out of 1,042
75th
Source: SEC filing on January 13, 2016.

Luly's colleagues

We found two more compensation records of executives who worked with Jay R. Luly at Enanta Pharmaceuticals in 2014.

2014

Yat Or

Enanta Pharmaceuticals

Chief Scientific Officer

2014

Paul Mellett

Enanta Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like